🔗 Permalink

Inventor profile of:

Markus MANDLER

City:

Vienna

Country:

Austria

Published Applications:

Last publication date:

2025-06-12

Top Assignees for applications by Markus MANDLER

The entities that hold a legal rights for patent applications filed by inventor MANDLER Markus:

Affiris AG 16 Vienna, Austria
AC Immune S.A. 2 Lausanne, Switzerland
Advantage Therapeutics, Inc. 1 Fort Lauderdale, FL United States

Recent patent applications by MANDLER Markus

Markus MANDLER from Vienna, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-12

US20250186596A1

Human necessities

A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN

#2 | 2025-06-12

US20250186595A1

Human necessities

A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN

#3 | 2025-06-12

US20250186580A1

Human necessities

A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN

#4 | 2023-06-29

US20230201320A1

Human necessities

MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHY

#5 | 2022-03-03

US20220062412A1

Human necessities

TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT

#6 | 2020-11-26

US20200369738A1

Chemistry; metallurgy

Treatment of Local Skin Hypotrophy Conditions

#7 | 2020-10-29

US20200338192A1

Human necessities

Treatment of Alzheimer's Disease (AD) with an aluminum salt

#8 | 2020-08-13

US20200254076A1

Human necessities

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy

#9 | 2020-02-06

US20200038487A1

Human necessities

PREVENTION AND TREATMENT OF NON-MELANOMA SKIN CANCER (NMSC)

#10 | 2017-06-08

US20170158744A1

Chemistry; metallurgy

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

#11 | 2017-03-02

US20170056495A1

Human necessities

Treatment of alzheimer'S disease (AD) with an aluminum salt

#12 | 2017-02-23

US20170049812A1

Human necessities

Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide

#13 | 2017-02-23

US20170049810A1

Human necessities

Treatment and prevention of alzheimer's disease (AD)

#14 | 2016-02-25

US20160054333A1

Physics

Method for detecting aSyn-specific antibodies in a biological sample

#15 | 2016-01-14

US20160008443A1

Human necessities

METHOD FOR TREATING A beta-AMYLOIDOSIS

#16 | 2015-10-29

US20150306194A1

Human necessities

METHOD FOR TREATING A SYNUCLEIOPATHY

#17 | 2015-04-02

US20150093432A1

Human necessities

COMPOSITION

#18 | 2015-04-02

US20150093431A1

Human necessities

COMPOSITIONS

#19 | 2013-10-31

US20130287807A1

Chemistry; metallurgy

COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

#20 | 2013-09-05

US20130230545A1

Human necessities

COMPOUNDS FOR TREATING BETA-AMYLOIDOSES

#21 | 2012-06-21

US20120156234A1

Human necessities

Means for treating synucleinopathies

#22 | 2011-07-14

US20110171243A1

Chemistry; metallurgy

Compounds for treating amyloidoses

#23 | 2011-04-28

US20110097351A1

Human necessities

Compounds for treating beta-amyloidoses

#24 | 2011-04-21

US20110092436A1

Human necessities

COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

#25 | 2011-04-21

US20110092434A1

Human necessities

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

InventorID:

424154 ⎘